Imed19 Betriebs GmbH

At Imed19 Betriebs GmbH in Vienna, research in cardiovascular diseases focuses on conditions such as heart failure, hypertension, and broader cardiovascular disease. These studies are designed to test new treatment approaches and understand whether they can better reduce major heart-related events and improve patient outcomes.

• Heart failure with preserved or mildly reduced ejection fraction and obesity
• Cardiovascular disease and prevention of major cardiac events
• Type 2 diabetes, high blood pressure, and established cardiovascular disease

The site is contributing to trials that evaluate whether emerging therapies can improve protection against hospitalization, urgent care visits, and cardiovascular death.

Clinical research in immune system diseases at this private practice site includes studies of ulcerative colitis and Crohn's disease. The main goal is to assess whether new therapies can help control inflammation, support symptom relief, and maintain disease improvement over time.

• Ulcerative colitis treatment and maintenance
• Crohn's disease treatment and maintenance
• Immune-mediated disease management

These trials reflect a strong interest in both short-term disease control and longer-term maintenance strategies for people living with chronic inflammatory conditions.